Okay, let's tackle this question. The question is about the origin of lymphoplasmacytic lymphoma. First, I need to recall the different types of lymphomas and their cell origins. Lymphomas are broadly categorized into Hodgkin and non-Hodgkin. Non-Hodgkin includes various subtypes like B-cell, T-cell, and NK-cell lymphomas.

Lymphoplasmacytic lymphoma specifically... Hmm, I think it's a B-cell lymphoma. Wait, why? Because plasma cells are derived from B-cells. But lymphoplasmacytic lymphoma is part of the spectrum of lymphomas that includes Waldenström macroglobulinemia. Right, Waldenström is a type of lymphoplasmacytic lymphoma characterized by IgM monoclonal gammopathy.

So the origin here would be B-cells. Let me check the options. The correct answer is B. B-cells. The other options might include T-cells, plasma cells, or other. Let's think about why others are wrong. T-cell lymphomas are different, like T-cell acute lymphoblastic. Plasma cells are the end stage of B-cell differentiation, but the lymphoma is in the plasmacytoid stage, not mature plasma cells. So the origin is B-cells.

Clinical pearl: Lymphoplasmacytic lymphoma is associated with IgM and Waldenström. Remember that B-cell origin is key here. So the correct answer is B.

**Core Concept**
Lymphoplasmacytic lymphoma is a **B-cell** neoplasm characterized by the proliferation of lymphoplasmacytoid cells (intermediate between lymphocytes and plasma cells). It is closely associated with **Waldenström macroglobulinemia**, where monoclonal IgM is produced due to clonal B-cell expansion.

**Why the Correct Answer is Right**
The neoplastic cells in lymphoplasmacytic lymphoma originate from **B-lymphocytes** that undergo malignant transformation. These cells exhibit plasmacytoid differentiation but retain some lymphoid features. The disease is marked by **IgM paraproteinemia**, hyperviscosity syndrome, and bone marrow infiltration. The B-cell lineage is confirmed by immunophenotyping (CD19, CD20, CD79a positivity) and genetic studies (e.g., MYD88 mutations).

**Why Each Wrong Option is Incorrect**
**Option A:** *T-cells* – Incorrect. T-cell lymphomas (e.g., peripheral T-cell lymphoma) have distinct morphology, immunophenotype (CD3, CD4/CD8), and clinical behavior.
**Option C:** *Plasma cells* – Incorrect. Plasma cell myeloma involves mature plasma cells, not lymphoplasmacytoid precursors.
**Option D:** *NK cells* – Incorrect. NK-cell lymphomas (e.g., nasal T/NK-cell lymphoma) are rare, EBV-associated, and CD56+/CD3-.

**Clinical Pearl / High-Yield Fact**
Remember: **"Lymphoplasmacytic = B-cell with IgM!"** It is the hallmark of Waldenström macroglobulinemia. Avoid confusing it with multiple myeloma (plasma cell origin) or

✓ Correct Answer: C. Post germinal centre B cell